A5083357018- Inflammatory Bowel Disease
- Microscopic Colitis
- Eosinophilic Esophagitis
- Gastroesophageal reflux and treatments
- COVID-19 and healthcare impacts
- Gastrointestinal Bleeding Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- Mycobacterium research and diagnosis
- Esophageal and GI Pathology
- COVID-19 and Mental Health
Taichung Veterans General Hospital
2023-2025
Despite industrialization and advances in healthcare, the prevalence of inflammatory bowel disease (IBD), which encompasses Crohn's (CD) ulcerative colitis (UC), is increasing Taiwan. Population-based studies can estimate incidence or IBD; however, there a lack information regarding phenotype. Therefore, this study was designed to investigate epidemiologic trends IBD Taiwan gain more comprehensive understanding. Patient data were reviewed from prospectively registered by Society (TSIBD). We...
Ulcerative colitis (UC) is a chronic inflammation of the gastrointestinal tract and characterized by alternating periods remission. Although UC incidence lower in Taiwan than Western countries, its impact remains considerable, demanding updated guidelines for addressing local healthcare challenges patient needs. The revised employ international standards recent research, emphasizing practical implementation within Taiwanese system. Since inception 2017, Society Inflammatory Bowel Disease has...
Crohn's disease (CD) is a chronic, fluctuating inflammatory condition that primarily affects the gastrointestinal tract. Although incidence of CD in Taiwan lower than Western countries, severity presentation appears to be similar between Asia and West. This observation indicates urgency for devising revised guidelines tailored unique reimbursement system, patient requirements Taiwan. The core objectives these updated include treatment choices integration treat-to-target strategy into...
The coronavirus disease 2019 (COVID-19) pandemic had a great impact on healthcare system and patients. This study aimed to evaluate the effect of COVID-19 perceptions patients with inflammatory bowel (IBD).